Ron DePinho: Advancing Pancreatic Cancer Interception Through RAS Targeting

Coverage, in order

1. 2d ago
   
   OncoDaily obscure study

   Ron DePinho: Advancing Pancreatic Cancer Interception Through RAS Targeting

   Ron DePinho, Professor of Department of Cancer Biology, Division of Discovery Science at MD Anderson Cancer Center, shared on LinkedIn: ”The ability to target RAS opens an important opportunity in pancreatic

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.